{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:08:53Z","timestamp":1793830133263,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01492-3","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T06:02:31Z","timestamp":1667628151000},"page":"1287-1292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Systematic Review on Anti-Yo\/PCA-1 Antibody: Beyond Cerebellar Ataxia in Middle-Aged Women with Gynecologic Cancer"],"prefix":"10.1007","volume":"22","author":[{"given":"Natalia Trombini","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia Rossoni","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"issue":"4","key":"1492_CR1","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine JCG, Desetret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"1492_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","volume":"267","author":"A Vogrig","year":"2020","unstructured":"Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26\u201335.","journal-title":"J Neurol"},{"issue":"6","key":"1492_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ana.410140603","volume":"14","author":"JE Greenlee","year":"1983","unstructured":"Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983;14(6):609\u201313.","journal-title":"Ann Neurol"},{"issue":"5","key":"1492_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ana.410180513","volume":"18","author":"KA Jaeckle","year":"1985","unstructured":"Jaeckle KA, Graus F, Houghton A, Cardon-Cardo C, Nielsen SL, Posner JB. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol. 1985;18(5):592\u2013600.","journal-title":"Ann Neurol"},{"key":"1492_CR5","doi-asserted-by":"crossref","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes (Contemporary Neurology Series, 79). Oxford University Press; 2011.","DOI":"10.1093\/med\/9780199772735.001.1"},{"issue":"10","key":"1492_CR6","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration I A clinical analysis of 55 anti-Yo antibody-positive patients. Neurol. 1992;42(10):1931\u20137.","journal-title":"Neurol"},{"issue":"10","key":"1492_CR7","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/archneurol.2011.128","volume":"68","author":"A McKeon","year":"2011","unstructured":"McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011;68(10):1282\u20139.","journal-title":"Arch Neurol"},{"issue":"2","key":"1492_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-510X(01)00467-1","volume":"185","author":"B Meglic","year":"2001","unstructured":"Meglic B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185(2):135\u20138.","journal-title":"J Neurol Sci"},{"issue":"2","key":"1492_CR9","first-page":"144","volume":"46","author":"A Goto","year":"2006","unstructured":"Goto A, Kusumi M, Wakutani Y, Nakaso K, Kowa H, Nakashima K. Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report. Rinsho Shinkeigaku. 2006;46(2):144\u20137.","journal-title":"Rinsho Shinkeigaku"},{"issue":"5","key":"1492_CR10","first-page":"368","volume":"53","author":"Y Li","year":"2020","unstructured":"Li Y, Liu Y, Jia Y, Jiao S. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma: one case report and literature review. Chin J Neurol. 2020;53(5):368\u201371.","journal-title":"Chin J Neurol"},{"issue":"3","key":"1492_CR11","first-page":"18","volume":"5","author":"K Xia","year":"2003","unstructured":"Xia K, Saltzman JR, Carr-Locke DL. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma. MedGenMed. 2003;5(3):18.","journal-title":"MedGenMed"},{"issue":"2","key":"1492_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/1531-8249(20010201)49:2<253::AID-ANA47>3.0.CO;2-3","volume":"49","author":"IJ Sutton","year":"2001","unstructured":"Sutton IJ, Fursdon Davis CJ, Esiri MM, Hughes S, Amyes ER, Vincent A. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol. 2001;49(2):253\u20137.","journal-title":"Ann Neurol"},{"key":"1492_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jocn.2016.10.034","volume":"36","author":"A Bruhnding","year":"2017","unstructured":"Bruhnding A, Notch D, Beard A. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma. J Clin Neurosci. 2017;36:71\u20132.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1492_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/cen3.12249","volume":"7","author":"JA Kim","year":"2015","unstructured":"Kim JA, Pinto A, Nucci MR, Lyons JL. Concomitant opsoclonus and ataxia and limbic encephalitis due to dual anti-RI and anti-Yo positive antibodies in uterine carcinosarcoma: a case report. Clin Expe Neuroimmunol. 2015;7(1):75\u201387.","journal-title":"Clin Expe Neuroimmunol"},{"issue":"3","key":"1492_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/0972-2327.138528","volume":"17","author":"A Bhargava","year":"2014","unstructured":"Bhargava A, Bhushan B, Kasundra GM, Shubhakaran K, Pujar GS, Banakar B. Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-Yo antibody mediated paraneoplastic cerebellar degeneration. Ann Indian Acad Neurol. 2014;17(3):355\u20137.","journal-title":"Ann Indian Acad Neurol"},{"issue":"2","key":"1492_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000052961","volume":"52","author":"PM Geomini","year":"2001","unstructured":"Geomini PM, Dellemijn PL, Bremer GL. Paraneoplastic cerebellar degeneration: neurological symptoms pointing to occult ovarian cancer. Gynecol Obstet Invest. 2001;52(2):145\u20136.","journal-title":"Gynecol Obstet Invest"},{"issue":"44","key":"1492_CR17","doi-asserted-by":"publisher","first-page":"e8468","DOI":"10.1097\/MD.0000000000008468","volume":"96","author":"N Kato","year":"2017","unstructured":"Kato N, Hashida G, Konaka K. Rehabilitation for a patient with anti-Yo antibody-positive paraneoplastic cerebellar degeneration caused by breast cancer: a case report and literature review. Med. 2017;96(44):e8468.","journal-title":"Med"},{"key":"1492_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1752-1947-6-155","volume":"6","author":"PK Panegyres","year":"2012","unstructured":"Panegyres PK, Graves A. Anti-Yo and anti-glutamic acid decarboxylase antibodies presenting in carcinoma of the uterus with paraneoplastic cerebellar degeneration: a case report. J Med Case Rep. 2012;6:155.","journal-title":"J Med Case Rep"},{"issue":"2","key":"1492_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ncponc0379","volume":"3","author":"A Santillan","year":"2006","unstructured":"Santillan A, Bristow RE. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer. Nat Clin Pract Oncol. 2006;3(2):108\u201312.","journal-title":"Nat Clin Pract Oncol"},{"issue":"3","key":"1492_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tjog.2014.03.012","volume":"54","author":"HJ Chien","year":"2015","unstructured":"Chien HJ, Lee CY, Chen LA, Wu CC, Chang CL. Paraneoplastic cerebellar degeneration in a patient with ovarian cancer. Taiwan J Obstet Gynecol. 2015;54(3):313\u20135.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"6","key":"1492_CR21","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12311-019-01045-1","volume":"18","author":"S Bhardwaj","year":"2019","unstructured":"Bhardwaj S, Khasani S, Benasher D, et al. Paraneoplastic cerebellar degeneration in nasopharyngeal carcinoma: a unique association. Cerebellum. 2019;18(6):1126\u20139.","journal-title":"Cerebellum"},{"issue":"3","key":"1492_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00415-009-5407-9","volume":"257","author":"CP Gilmore","year":"2009","unstructured":"Gilmore CP, Elliott I, Auer D, Maddison P. Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol. 2009;257(3):490\u20131.","journal-title":"J Neurol"},{"issue":"9","key":"1492_CR23","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/pon.3270","volume":"22","author":"RG Key","year":"2013","unstructured":"Key RG, Root JC. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review. Psychooncol. 2013;22(9):2152\u20135.","journal-title":"Psychooncol"},{"issue":"6","key":"1492_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0003-9993(00)90121-7","volume":"81","author":"S Liu","year":"2000","unstructured":"Liu S, Tunkel R, Lachmann E, Nagler W. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report. Arch Phys Med Rehabil. 2000;81(6):834\u20136.","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"1492_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/PGP.0b013e3182237ca6","volume":"30","author":"KJ Selby","year":"2011","unstructured":"Selby KJ, Warner J, Klempner S, Konstantinopoulos PA, Hecht JL. Anti-Yo antibody associated with occult fallopian tube carcinoma. Int J Gynecol Pathol. 2011;30(6):536\u20138.","journal-title":"Int J Gynecol Pathol"},{"key":"1492_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.wneu.2018.01.105","volume":"112","author":"A Enr\u00edquez-Marulanda","year":"2018","unstructured":"Enr\u00edquez-Marulanda A, Beltr\u00e1n-Osorio LD, Escobar LA, Granados AM, Vel\u00e1squez-Lasprilla F, Orozco JL. Anti-Yo-associated paraneoplastic cerebellar degeneration manifesting as acute cerebellitis with posterior cranial fossa hypertension. World Neurosurg. 2018;112:117\u201322.","journal-title":"World Neurosurg"},{"issue":"4","key":"1492_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2169\/internalmedicine.1398-18","volume":"58","author":"Y Hashimoto","year":"2019","unstructured":"Hashimoto Y, Komatsu K, Nakagawa T, Matsumoto S. Transient diffusion-weighted imaging hyperintensity of the cerebellar cortex in paraneoplastic cerebellar degeneration. Intern Med. 2019;58(4):619\u201320.","journal-title":"Intern Med"},{"issue":"4","key":"1492_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","volume":"135","author":"M Small","year":"2018","unstructured":"Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, et al. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 2018;135(4):569\u201379.","journal-title":"Acta Neuropathol"},{"key":"1492_CR29","unstructured":"The Human Protein Atlas. (2022, May 31). Retrieved July 14, 2022, from http:\/\/www.proteinatlas.org."},{"issue":"2","key":"1492_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/jnp.12.2.193","volume":"12","author":"M Rapoport","year":"2000","unstructured":"Rapoport M, van Reekum R, Mayberg H. The role of the cerebellum in cognition and behavior: a selective review. J Neuropsychiatry Clin Neurosci. 2000;12(2):193\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"1492_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s004010050460","volume":"91","author":"J Verschuuren","year":"1996","unstructured":"Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 1996;91(5):519\u201325.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1492_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1215\/S1152851703000395","volume":"6","author":"S Vernino","year":"2004","unstructured":"Vernino S, O\u2019Neill BP, Marks RS, O\u2019Fallon JR, Kimmel DW. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol. 2004;6(1):55\u201362.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1492_CR33","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1212\/NXI.0000000000000963","volume":"8","author":"I Herdlev\u00e6r","year":"2021","unstructured":"Herdlev\u00e6r I, Haugen M, Mazengia K, Totland C, Vedeler C. Paraneoplastic cerebellar degeneration: the importance of including CDR2L as a diagnostic marker. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e963.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"1492_CR34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"G Francesc","year":"2004","unstructured":"Francesc G, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01492-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T03:03:26Z","timestamp":1700363006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01492-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01492-3","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]},"assertion":[{"value":"24 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.Consent for Publication.Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}